体外模拟心肺转流4小时中胰岛素动态变化的体外研究
该体外研究在两种体外循环回路中模拟心肺转流4小时,发现含红细胞的回路中胰岛素浓度显著下降,传统回路下降92%且溶血更明显,而仅含血浆的传统回路胰岛素无显著下降,溶血指数与胰岛素变化高度相关。
要点
- 含红细胞的体外循环回路中胰岛素4小时内显著丢失,传统回路丢失多于微创回路。
- 仅含血浆的回路胰岛素无显著下降,提示溶血产物可能是胰岛素降解的主要因素。
- 溶血指数与胰岛素百分比变化高度相关,支持溶血致胰岛素降解的机制。
核心结论
- 模拟心肺转流4小时中,仅含血红蛋白的体外循环回路出现胰岛素水平大幅下降。
- 传统体外循环回路胰岛素下降更显著且溶血程度更高。
- 溶血产物对胰岛素的降解可能是胰岛素丢失的更主要因素,而非回路表面吸附。
研究设计与样本
- 体外实验:6个传统体外循环回路和6个微创体外循环回路,以压积红细胞与解冻新鲜冰冻血浆1:1预充。
- 另在传统回路中以仅解冻新鲜冰冻血浆进行4次额外实验。
- 加入人胰岛素(Actrapid)目标血浆浓度400 mU/L,基线和此后每小时测胰岛素浓度和溶血指数。
- 终点为4小时后胰岛素水平较基线变化和溶血指数,采用饱和线性混合效应回归模型分析。
主要发现
- 含红细胞的微创回路胰岛素浓度下降63%(95% CI,48%-77%)。
- 含红细胞的传统回路胰岛素浓度下降92%(95% CI,77%-106%)。
- 传统回路胰岛素丢失显著高于微创回路(P = .022)。
- 仅含血浆的传统回路胰岛素无显著下降(-4%;95% CI,-21%至14%)。
- 微创回路溶血指数从68(95% CI,46-91)升至76(95% CI,54-98),传统回路从81(95% CI,59-103)升至121(95% CI,99-143)。
临床怎么用
- 体外循环期间应关注溶血对胰岛素浓度的影响,尤其使用传统回路时。
- 监测溶血指数可能有助于预判胰岛素丢失程度,指导血糖管理。
- 微创体外循环回路可能减少胰岛素丢失,但需临床研究验证。
局限性
- 研究为体外模拟实验,不能完全代表临床心肺转流过程。
- 样本量较小,仅6个传统回路和6个微创回路,另4次血浆实验。
- 未评估其他可能影响胰岛素浓度的因素,如温度、血流动力学等。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hyperglycemia is common in patients undergoing cardiovascular surgery with cardiopulmonary bypass. We hypothesize that intraoperative hyperglycemia may be, at least partially, attributable to insulin loss due to adhesion on artificial surfaces and/or degradation by hemolysis. Thus, our primary aim was to investigate the loss of insulin in 2 different isolated extracorporeal circulation circuits (ECCs), that is, a conventional ECC (cECC) with a roller pump, and a mini-ECC (MiECC) system with a centrifugal pump. The secondary aim was to assess and compare the relationship between changes in insulin concentration and the degree of hemolysis in our 2 ECC models. METHODS: Six cECC and 6 MiECC systems were primed with red packed blood cells and thawed fresh-frozen plasma (1:1). Four additional experiments were performed in cECC using only thawed fresh-frozen plasma. Human insulin (Actrapid) was added, targeting a plasma insulin concentration of 400 mU/L. Insulin concentration and hemolysis index were measured at baseline and hourly thereafter. The end points were the change in insulin level after 4 hours compared to baseline and hemolysis index after 4 hours. The insulin concentration and hemolysis index were analyzed by means of a saturated linear mixed-effect regression model with a random offset for each experiment to account for the repeated measure design of the study, resulting in mean estimates and 95% confidence intervals (CIs) of the primary end points as well as of pairwise contrasts with respect to ECC type. RESULTS: Insulin concentration decreased by 63% (95% CI, 48%-77%) in the MiECC and 92% (95% CI, 77%-106%) in the cECC system that contained red blood cells. Insulin loss was significantly higher in the cECC system compared to the MiECC ( P = .022). In the cECC with only plasma, insulin did not significantly decrease (-4%; 95% CI, -21% to 14%). Hemolysis index in MiECC increased from 68 (95% CI, 46-91) to 76 (95% CI, 54-98) after 4 hours, in cECC from 81 (95% CI, 59-103) to 121 (95% CI, 99-143). Hemolysis index and percent change of insulin showed an excellent relationship (r = -0.99, P < .01). CONCLUSIONS: Our data showed that insulin levels substantially decreased during 4 hours of simulated cardiopulmonary bypass only in the ECC that contained hemoglobin. The decrease was more pronounced in the cECC, which also exhibited a greater degree of hemolysis. Our results suggest that insulin degradation by hemolysis products may be a stronger contributor to insulin loss than adhesion of insulin molecules to circuit surfaces.
引用
- Schweizer T, Nossen CM, Galova B, et al. In Vitro Investigation of Insulin Dynamics During 4 Hours of Simulated Cardiopulmonary Bypass. Anesth Analg. 2024. PMID: 38861464. doi:10.1213/ANE.0000000000007106
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。